Differential Diagnostics Global Market Report 2023: Rising Number of Diagnostic Tests Available Bolsters Sector
30 mars 2023 07h38 HE
|
Research and Markets
Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "Differential Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Treatment Type (Chest Pain,...
Global Sepsis Diagnostics Market Analysis 2022-2026 by Assay, Cause, Product, Lab, and Place - Current and Future Market Landscape
17 juin 2022 04h03 HE
|
Research and Markets
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "Sepsis Diagnostics Global Markets by Assay, by Cause, by Product, by Lab, and by Place. With Executive and Consultant Guides and Sepsis Market Analysis...
Global Sepsis Diagnostics Markets Report 2022-2027: Cost Curve, The Diagnostics Dillemma, & Adoption Lag and Cost Control Limiting Growth
24 janv. 2022 04h43 HE
|
Research and Markets
Dublin, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The "Sepsis Diagnostics - Global Markets by Assay, by Cause, by Product, by Lab, and by Place, with Executive and Consultant Guides and COVID-19 Related...
Amydis Awarded $3 Million NIH Grant to Explore Novel Alpha Synuclein Retinal Tracer in Non-human Primate Models of Parkinson’s Disease and Multiple System Atrophy
11 oct. 2021 07h00 HE
|
Amydis, Inc.
SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
Global Sepsis Diagnostics Markets Report 2020-2021 & 2025 - Rapid Results & COVID Pandemic Drive Race for a Predictive Sepsis Diagnostic
20 mai 2021 07h18 HE
|
Research and Markets
Dublin, May 20, 2021 (GLOBE NEWSWIRE) -- The "Sepsis Diagnostics - Global Markets by Assay, by Cause, by Product, by Lab, and by Place, with Executive and Consultant Guides and COVID-19 Related...
DiamiR Announces Oral Presentation at 2016 Alzheimer's Association International Conference
21 juil. 2016 08h30 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ --(Marketwired - July 21, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that the...
DiamiR Announces Oral Presentation at Biomarkers Summit 2016
18 mars 2016 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 18, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that...